▶ Robot Bacteriophage against microbiome associated with colorectal cancer ▶ Bacteriophage Improvem...
* iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment ...
* It was confirmed the presence of Prophage and Jamphage in the Alkalihalobacillus clausii * Pr...
* Secured the effectiveness confirming data of PHAGERIA® technology for colorectal cancer organoi...
* Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in...
* Including the contract transfers of the external studies planned for the successful out-licensi...
* The transposon technology development following the customized CRISPR/Cas system for bacterioph...
* CRISPR/Cas system for bacteria that are not E. coli or Streptococcus pyogenes * Customized ge...
* Shows potent and rapid antibacterial activity against clinical isolates in Europe and Korea bot...
* TONABACASE, the first registered INN by WHO for Endolysin * First-in-Class Endolysin-based Dru...
* A novel drug candidate for anthrax received orphan drug designation (ODD) by the US FDA. BOSTON...
It aims to promote strategic collaborations in global while also highlights its many innovative adv...